MTVA Stock Analysis: Buy, Sell, or Hold?
MTVA - MetaVia Inc. Common Stock
$1.46
0.02 (1.39%)
â˛
5d:
-2.01%
30d:
-3.31%
90d:
-49.13%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When MTVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MTVA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MTVA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MTVA is currently trading at $1.46, which is considered fair relative to its 30-day fair value range of $1.41 to $1.59.
Technical Outlook: Technically, MTVA is showing sideways momentum. The price is currently testing key support at $1.42. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MTVA scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.33 (+1224.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MTVA is showing sideways momentum. The price is currently testing key support at $1.42. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MTVA scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $19.33 (+1224.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.41 -
$1.59
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1224.2% below Wall St target ($19.33)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.41 -
$1.59
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.42
Resistance Level
$1.54
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.62
Wall Street Target
$19.33
(+1224.2%)
Share & Embed Analysis
Last updated: August 24, 2026 6:59 AM ET
Data refreshes hourly during market hours. Next update: 7:59 AM
Data refreshes hourly during market hours. Next update: 7:59 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$840 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
